News-Medical.Net on MSN
Aptamer-based wearables revolutionize continuous health tracking
Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health ...
Leading Health & Wellness brand introduces the addition of Nucleic Acid Building Blocks to their PerfectAmino tablets. LOS ANGELES, April 19, 2024 /PRNewswire/ -- BODYHEALTH ® has announced its latest ...
DNA is the poster child for high-specificity binding. As long as their base sequences match, two complementary strands of DNA can navigate through a sea of biomolecules, find each other, and hold fast ...
A researcher is developing a patent-pending platform technology called LENN that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells. A ...
Aptamers, nucleic acids capable of selectively binding to viruses, proteins, ions, small molecules, and various other targets, are garnering attention in drug development as potential antibody ...
Viral diseases pose a significant global health challenge, placing substantial strain on healthcare systems. Accurate identification of viral infections is crucial for monitoring outbreaks, managing ...
Company to Initiate First-in-Human Phase 1 Clinical Trial in Q2 2026ROCKVILLE, Md.--(BUSINESS WIRE)--#Clinicaltrials--Immunomic Therapeutics, Inc. (“ITI”), a privately held clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results